Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

TRAF3: A novel regulator of mitochondrial physiology and metabolic pathways in B lymphocytes

Frontiers in Oncology(2023)10.3389/fonc.2023.1081253Source: DataRank Database

TRAF3: A novel regulator of mitochondrial physiology and metabolic pathways in B lymphocytes is a research paper published in Frontiers in Oncology (2023). On theSindex it has a DataRank of 0. It has been cited 7 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access7 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (6 grants)Impact (FWCI 0.65)OA: goldTopics (23)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (3)

Samantha Gokhale ORCID,Ping Xie ORCID,Jaeyong Jung ORCID

Live enrichment

PubMed:36776285 OpenAlex:https://openalex.org/W4318193123

Office of Extramural Research, National Institutes of Health

Grant: R01 CA158402 , R21 AI128264 , P30CA072720

National Institutes of Health

Grant: 1R01CA158402-01A1

Molecular mechanisms of B cell malignant transformation

National Institutes of Health

Grant: 1R21AI128264-01A1

Roles of TRAF3 in myeloid derived suppressor cells in chronic inflammation

National Institutes of Health

Grant: 3P30CA072720-07S2

CANCER CENTER SUPPORT GRANT

NCI NIH HHS

Grant: R01 CA158402

NIAID NIH HHS

Grant: R21 AI128264

FWCI

0.65

Citation Percentile

0.6%

Citation Trend

2023

2024

2025

goldLicense: cc-by

journalhttps://www.frontiersin.org/articles/10.3389/fonc.2023.1081253/pdf

publisherhttps://www.frontiersin.org/articles/10.3389/fonc.2023.1081253/pdf

publisherhttps://www.frontiersin.org/articles/10.3389/fonc.2023.1081253/full

journalhttps://doi.org/10.3389/fonc.2023.1081253

repositoryhttps://pubmed.ncbi.nlm.nih.gov/36776285

Fields of Study

Ubiquitin and proteasome pathwaysCell death mechanisms and regulationPeptidase Inhibition and Analysis0301 basic medicine03 medical and health sciences

Keywords

Mitochondrionmitochondrial fusionCell biologyBiologyMitochondrial fissionRegulatorCellMitochondrial DNABiochemistryGenemitochondriaTRAF3OncologyNeoplasms. Tumors. Oncology. Including cancer and carcinogenslymphomasmetabolismRC254-282B lymphocytes

Sustainable Development Goals

SDG 0: Good health and well-being